Avacta Group
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Avacta Group
- Christina Coughlin, Chief Executive Officer and Director
- Eliot Forster, Non-Executive Chairman of the Board
- Paul Fry, Non-Executive Director
Popular executive movements at Avacta Group
- Alastair Smith, Chief Executive Officer & Director, has left the company (posted on April 30 2024).
- Christina Coughlin, who was Director and Head of Research and Development, is promoted to Chief Executive Officer and Director (posted on April 30 2024).
- Christina Coughlin who is Non-Executive Director, will be promoted to Director and Head of Research and Development on Feb. 1, 2024 (posted on January 21 2024).
Create your alert
to follow the executive moves at Avacta Group.
Biotechnology
Avacta Group has 2,295 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
Popular contacts in Biotechnology
News
Press releases by Avacta Group
- Location | Avacta Life Sciences Limited
- Location | Avacta Life Sciences Limited
- Website Disclaimer | Avacta Life Sciences Limited
- LG Chem renews license triggering payment to Avacta | Avacta Life Sciences Limited
- Re: Press Speculation | Avacta Life Sciences Limited
Social media about Avacta Group
- Avacta Group on Wikipedia, Google News & Yahoo Finance
- Avacta Group on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Shaun Chilton 
Call Avacta Group at +44 844...
